BACKGROUND: Poor sleep quality is a common, persistent, and important problem to patients with end-stage renal disease (ESRD). This report examines whether sleep quality is associated with dialysis treatment factors and other modifiable clinical factors in a large group of hemodialysis (HD) patients. METHODS: Cross-sectional analyses were conducted on baseline data collected from participants in the Frequent Hemodialysis Network trials. Sleep quality was measured using the Medical Outcomes Study Sleep Problems Index II (SPI II), a 9-item measure of sleep quality with higher scores reflecting poorer sleep quality. RESULTS: The participants had an age of 51.2 ± 13.6 years, 61% were male, 38% were black, and 42% had diabetes. Higher pre-dialysis serum phosphorus (per 0.5 mg/ml) (OR 0.91; 95% CI 0.85, 0.96) and depression (OR 0.16; 95% CI 0.10, 0.25) were independently associated with decrements in sleep quality. There was also a difference in time to recovery from dialysis for the fourth versus the first SPI II quartile (5.1 h; p < 0.0001). CONCLUSION: These findings underscore the link between sleep and daytime function and suggest that improving sleep may provide an opportunity to improve outcomes in ESRD. Whether sleep problems may be improved by reduction of serum phosphorus or treatment of depression in the HD population merits further investigation.
BACKGROUND: Poor sleep quality is a common, persistent, and important problem to patients with end-stage renal disease (ESRD). This report examines whether sleep quality is associated with dialysis treatment factors and other modifiable clinical factors in a large group of hemodialysis (HD) patients. METHODS: Cross-sectional analyses were conducted on baseline data collected from participants in the Frequent Hemodialysis Network trials. Sleep quality was measured using the Medical Outcomes Study Sleep Problems Index II (SPI II), a 9-item measure of sleep quality with higher scores reflecting poorer sleep quality. RESULTS: The participants had an age of 51.2 ± 13.6 years, 61% were male, 38% were black, and 42% had diabetes. Higher pre-dialysis serum phosphorus (per 0.5 mg/ml) (OR 0.91; 95% CI 0.85, 0.96) and depression (OR 0.16; 95% CI 0.10, 0.25) were independently associated with decrements in sleep quality. There was also a difference in time to recovery from dialysis for the fourth versus the first SPI II quartile (5.1 h; p < 0.0001). CONCLUSION: These findings underscore the link between sleep and daytime function and suggest that improving sleep may provide an opportunity to improve outcomes in ESRD. Whether sleep problems may be improved by reduction of serum phosphorus or treatment of depression in the HD population merits further investigation.
Authors: G M Devins; S M Edworthy; L C Paul; H Mandin; T P Seland; G Klein; C G Costello; C M Shapiro Journal: J Psychosom Res Date: 1993 Impact factor: 3.006
Authors: Luke Rodriguez; Hocine Tighiouart; Tammy Scott; Kristina Lou; Lena Giang; Eric Sorensen; Daniel E Weiner; Mark J Sarnak Journal: J Nephrol Date: 2013 Jan-Feb Impact factor: 3.902
Authors: Mark L Unruh; Brett Larive; Paul W Eggers; Amit X Garg; Jennifer J Gassman; Fredric O Finkelstein; Paul L Kimmel; Glenn M Chertow Journal: Nephrol Dial Transplant Date: 2016-04-15 Impact factor: 5.992
Authors: Jessica Fitzpatrick; Eric S Kerns; Esther D Kim; Stephen M Sozio; Bernard G Jaar; Michelle M Estrella; Larisa G Tereshchenko; Jose M Monroy-Trujillo; Rulan S Parekh; Ghada Bourjeily Journal: J Clin Sleep Med Date: 2021-08-01 Impact factor: 4.324